Company page

Opthea Limited

Opthea Limited (Ticker: OPT) is a public company based in Australia with a market capitalization of approximately AUD 13.42 million. The company is focused on developing innovative therapies for eye diseases. Opthea is committed to advancing its research and clinical programs to address unmet medical needs in the ophthalmology sector.

profileOPT:ASXAI content: aiUpdated June 24, 2026/company/opthea-ltd/c-qsopfc0w
Opthea Limited logo
Ticker
OPT:ASX
Asset type
Stock
Market cap
$13.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD